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the recombination with nonpolio
enteroviruses is important. These
VDPVs have major implications for
the cessation of immunization with
OPV after certification that wild PV
has been eradicated.
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To the Editor: Recently West Nile
virus (WNV) infection has been
reported in three alligators (Alligator
sp.) from central Florida (1) and one
captive crocodile monitor (Varanus
salvadori) with neurologic signs from
the District of Columbia and
Maryland area (2). These first reports
of the virus in American reptiles high-
light the possible role of this group of
vertebrates in the WNV life cycle. To
our knowledge, WNV in a reptile was
reported only once before in a sero-
survey conducted in Israel from 1965
to 1966, in which 22 reptiles and 96
amphibians were tested for hemagglu-
tination-inhibiting antibodies against
several viruses, including WNV; one
turtle (Clemmys caspica) was
seropositive (3). Experimental infec-
tion of the lake frog (Rana ridibunda)
with a Russian strain of WNV result-
ed in high levels of viremia (4). At
present, the role of reptiles and
amphibians in the life cycle and epi-
demiology of WNV is not known.
We report, for the first time, WNV
infection in crocodiles (Crocodylus
niloticus). To assess the potential role
of crocodiles in the life cycle of WNV
in Israel, serum specimens were col-
lected from 20 healthy crocodiles on a
commercial farm in the Negev Desert,
in southern Israel (31°14′N, 34°19′E).
The crocodiles came from two sepa-
rate breeding farms (32°03′N,
35°26′E and 30°18′N, 35°07′E) in the
Syrian-African Rift Valley, which is
on the main route of bird migration
from Africa to Europe. Five males and
15 females, 1–2.5 years of age, were
examined. Blood was withdrawn from
the crocodiles’ ventral caudal vein,
separated by centrifugation, and kept
at –20°C until analyzed. Neutralizing
antibody titers were determined
against WN-goose-98 (5) and
attempts to isolate the virus were per-
formed by using Vero cell culture (6)
and by using direct reverse transcrip-
tion–polymerase chain reaction (RT-
PCR) on the serum specimens. To
eliminate the possibilities of nonspe-
cific reaction, all serum samples were
concurrently tested for the only other
flavivirus known to be present in
Israel; Israeli turkey meningo-
encephalitis virus (ITV) (7). Because
ITV does not produce cytopathic
effects (CPE) in Vero cells, virus neu-
tralization was conducted on BHK
cells for both WNV and ITV by using
WN-goose-98 and ITV (vaccine
strain). In this case, the virus stocks
(10-4.2  50% tissue culture infective
dose) were diluted 1:400, and virus
neutralization titers were checked 3
days later.
Viral RNA was extracted from
serum samples with the QIAamp
RNA blood kit (QIAGEN, Valencia,
CA) , according to the manufacturer’s
protocol and resuspended in 30 µl of
RNase-free water. The primer pair
WN240-Kun848 (respective genome
positions 5′: 848 and 1,645) was used
to synthesize an 800-bp product in the
E gene region (8,9). The resulting
DNA fragment was visualized on888 Emerging Infectious Diseases • Vol. 9, No. 7, July 2003
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1.5% agarose gel stained with ethidi-
um bromide.
The seroprevalence rate in the first
set of virus neutralization assays in
Vero cells was 14/20 (70%, with titers
ranging from 1:20 to 1:320 [3x1:20,
3x1:40, 3x1:80, 2x1:160, 3x1:320]).
No differences were discernible in
either the seroprevalence rate or in the
average titers of crocodiles from two
different breeding farms. In BHK
cells, a similar seroprevalence rate
was observed, with titers ranging from
1:40 to 1:1,280 (3x1:40, 2x1:80,
1x1:160, 4x1:320, 3x1:640,
1x1:1280). All serum samples, except
one, were <1:10 against ITV virus,
which had a titer of 1:640 against
WNV and 1:10 against ITV. Viremia
was not detected in any of the 20 sam-
ples in Vero cell culture or by RT-PCR.
These results demonstrate a high
rate of infection with WNV in croco-
diles in Israel. The crocodiles may
have been exposed to the virus during
the summer at their present location,
since no difference in prevalence was
seen between the two groups (which
differed only in the farm of origin)
and since the younger crocodiles had
been hatched in the spring of 2002.
Furthermore, a cross-reaction with the
other prevalent flavivirus in Israel,
ITV, was ruled out. Preliminary
results from an equine seroprevalence
study (involving 800 horses over a 3-
year period) of virus neutralization
antibodies to WNV collected during
fall 2002, indicate that most horses
sampled in Israel’s Arava Valley (a
desert in the Syrian-African Rift near
the Jordanian and Egyptian borders)
and the Gulf of Aqaba/Eilat (30°59′N,
35°18′E to 29°34′N, 34°57′E) (85%,
79/90) were positive (A. Steinman
and S. Tal, unpub. data,). WNV was
also isolated from mosquitoes in the
same region (10). The seroprevalence
of WNV antibodies among horses and
local birds from the Negev Desert is
not known nor is the time when the
horses acquired WNV infection.
However, the isolation of WNV from
mosquitoes (10) and the presence of
antibodies to WNV in young croco-
diles demonstrate arboviral activity in
this region in the summer of 2002,
although clinical cases were few. That
virus was not isolated from crocodiles
in late November (past outbreaks of
WNV in Israel mainly occurred
between August and October) (6,11).
WNV has been endemic in Israel
since the early 1950s (12). More
recently, in the summer of 2000, an
extensive outbreak occurred, affecting
hundreds of people (11), dozens of
horses (6), and several flocks of geese
(5). However, no deaths of crocodiles
were reported. This contrasts with the
report from Florida (1), where WNV
was isolated from dead alligators, and
where hundreds of cases of sudden
death had been reported in previous
years; these deaths are now suspected
to result, at least in part, from WNV
disease. 
The role of various reptile species
in the epidemiology of other
arboviruses such as western equine
encephalitis, eastern equine
encephalitis, and Venezuelan equine
encephalitis is well documented
(13–15). At present, the role of rep-
tiles and amphibians in the life cycle
and epidemiology of WNV is not
known, and further research is neces-
sary.
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"I must have made this molecule before;
It is familiar to the core!"
Said a yeast cell emerging from mitosis,
With no experience yet in synthesis.
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To the Editor: Rickettsia aeschli-
mannii is a pathogenic spotted fever
group rickettsia first isolated from
Hyalomma marginatum ticks collect-
ed in Morocco in 1997 (1). Later
found in H. marginatum ticks from
Zimbabwe, Niger, Mali, and Portugal
(2),  R. aeschlimannii has also been
found in a Rhipicephalus appendicu-
latus tick attached to the right thigh of
a patient in South Africa (3). These
data suggest a broad geographic dis-
tribution for R. aeschlimannii and the
possibility that tick species other than
H. marginatum may also be suitable
vectors for this rickettsia.
The pathogenicity of Rickettsia
aeschlimannii  in humans has been
demonstrated by Raoult et al. (4) in a
French patient who became ill after
returning from a trip to Morocco. The
patient exhibited symptoms similar to
those of Mediterranean spotted fever
(MSF) produced by R. conorii, with a
tache noire–like eschar on his ankle,
fever (39.5°C), and a generalized
maculopapular skin rash. The second
documented and most recent case of
human infection by R. aeschlimannii
occurred in a South African man who
was bitten by R. appendiculatus; an
eschar also developed around the tick
attachment site on this patient (3). He
was aware of the risk for tick-trans-
mitted disease, so he removed the tick
and administered doxycycline; he did
not develop additional symptoms.
Over the past 6 years, throughout
the region of Castilla y León, north-
western Spain, we have collected and
identified 3,059 ticks belonging to 15
species (unpub. data) that were
attached to persons living in this terri-
tory. We have systematically analyzed
the ticks by polymerase chain reaction
(PCR) to detect those infected with
Borrelia burgdorferi,  Anaplasma
phagocytophila, and Rickettsia spp.
This procedure enabled us to identify,
for the first time in Spain, R. aeschli-
mannii in 35 tick specimens belong-
ing to H. marginatum and to another
five species.
During the 6-year study, ticks
found on patients who sought medical
advice in the hospitals and healthcare
centers of Castilla y León were
removed and referred to our laborato-
ry for identification and analysis. Each
tick was first disinfected by immersion
in 70% alcohol, rinsed in sterile water,
and dried on sterile filter paper. We
then extracted DNA in 5% Chelex-
100, according to the method of
Guttman et al. (5). In searching for
Rickettsia spp., we proceeded as
described by La Scola and Raoult (6):
All DNA samples were first tested for
a fragment of the rickettsial gltA gene
(7), and then, in the gltA-positive sam-
ples, a fragment of the rickettsial
ompA gene (8) was amplified,
sequenced, and compared with gene
databases for identification. The gltA
amplicon was sequenced only when
the ompA was not successfully ampli-
fied. To prevent DNA contamination
and the carryover of amplified prod-
ucts, we used sterile tools at all times
and carried out each step of the analy-
sis (extracting DNA, preparing the
reaction mixture, and amplifying and
analyzing the PCR product) in separat-
ed work areas. Two negative controls
(Milli-Q water and DNA from labora-
tory-reared noninfected ticks) were
included in each amplification trial.
These controls were never amplified.
We obtained 21 ompA amplicons
(629–632 bp) from 21 ticks. One